NCT06138574View on ClinicalTrials.gov

Effects of Dexmetomidine and Remifentanil Used for Controlled Hypotension in Septorhinoplasty Surgery on Cardiac Electrophysiology: Prospective Randomized Study

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

March 30, 2024

Conditions

Rhinoplasty Surgery

Interventions

DRUG

Dexmedetomidine

After the induction of general anesthesia, one group (Group: 1) will be administered dexmedotomidin infizyon and group (Group :2)remifentanil

DRUG

Remifentanil

All Listed Sponsors

lead

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

OTHER

NCT06138574 - Effects of Dexmetomidine and Remifentanil Used for Controlled Hypotension in Septorhinoplasty Surgery on Cardiac Electrophysiology: Prospective Randomized Study | Biotech Hunter | Biotech Hunter